Could a lighter MS treatment keep the disease at bay?
NCT ID NCT07757568
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This study tests whether people with relapsing-remitting multiple sclerosis (MS) who have been stable on anti-CD20 therapies can safely switch to a fumarate drug like Tecfidera or Vumerity. The goal is to see if the switch keeps the disease inactive—meaning no relapses, no new brain lesions, and no worsening disability—over two years. Participants must have had no new disease activity for at least two years and be on anti-CD20 therapy for at least one year. The study will also measure a blood biomarker of nerve damage to check for subtle changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dimethyl fumarate (Tecfidera) or diroximel fumarate (Vumerity)
- What this could lead to
- If successful, this could offer a safer, more convenient long-term option for people with stable MS, reducing the need for stronger immunosuppressive therapy.
- What could go wrong
- This is a small pilot study with only 11 participants, so results may not apply broadly. There is a risk that switching could allow disease activity to return.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) RELAPSING REMITTING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado, Denver
Aurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain scans to reveal if new MS drug quietly calms inflammation
- A motorized hip brace may help MS patients walk better — small study puts it to the test
- Ear stimulation may help repair nerve damage in multiple sclerosis
- Could a gentle zapping of the brain ease MS fatigue and brain fog?
- Gentle exercise with cuffs may boost muscle in MS patients
- Placebo power: fake TENS and kind words may ease MS fatigue